Challenges for molecular magnetic resonance imaging

E Terreno, DD Castelli, A Viale, S Aime - Chemical reviews, 2010 - ACS Publications
Challenges for Molecular Magnetic Resonance Imaging | Chemical Reviews ACS ACS
Publications C&EN CAS Find my institution Log In Chemical Reviews ACS Publications. Most …

Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers

FM Kievit, M Zhang - Advanced materials, 2011 - Wiley Online Library
Cancer nanotheranostics aims to combine imaging and therapy of cancer through use of
nanotechnology. The ability to engineer nanomaterials to interact with cancer cells at the …

Large-Scale Synthesis of Uniform and Extremely Small-Sized Iron Oxide Nanoparticles for High-Resolution T1 Magnetic Resonance Imaging Contrast Agents

BH Kim, N Lee, H Kim, K An, YI Park… - Journal of the …, 2011 - ACS Publications
Uniform and extremely small-sized iron oxide nanoparticles (ESIONs) of< 4 nm were
synthesized via the thermal decomposition of iron–oleate complex in the presence of oleyl …

Inorganic nanoparticles for MRI contrast agents

HB Na, IC Song, T Hyeon - Advanced materials, 2009 - Wiley Online Library
Various inorganic nanoparticles have been used as magnetic resonance imaging (MRI)
contrast agents due to their unique properties, such as large surface area and efficient …

Manganese dioxide nanoparticles protect cartilage from inflammation-induced oxidative stress

S Kumar, IM Adjei, SB Brown, O Liseth, B Sharma - Biomaterials, 2019 - Elsevier
Oxidative stress has been implicated in the pathogenesis of osteoarthritis and has become
an important therapeutic target. Investigations of various antioxidant supplements, reactive …

Manganese-based MRI contrast agents: past, present, and future

D Pan, AH Schmieder, SA Wickline, GM Lanza - Tetrahedron, 2011 - Elsevier
Conclusion Manganese offers great advantages as a T1-weighted MR contrast agent due to
its favorable electronic configuration and enriched biochemical features. However …

Mesoporous Silica-Coated Hollow Manganese Oxide Nanoparticles as Positive T1 Contrast Agents for Labeling and MRI Tracking of Adipose-Derived Mesenchymal …

T Kim, E Momin, J Choi, K Yuan, H Zaidi… - Journal of the …, 2011 - ACS Publications
Mesoporous silica-coated hollow manganese oxide (HMnO@ mSiO2) nanoparticles were
developed as a novel T 1 magnetic resonance imaging (MRI) contrast agent. We …

A Prussian Blue‐Based Core–Shell Hollow‐Structured Mesoporous Nanoparticle as a Smart Theranostic Agent with Ultrahigh pH‐Responsive Longitudinal Relaxivity

X Cai, W Gao, M Ma, M Wu, L Zhang… - Advanced …, 2015 - Wiley Online Library
DOI: 10.1002/adma. 201503381 chelates, which can produce positive contrast
enhancement in T1-weighted MRI, have been clinically used for tumor diagnosis. However …

[HTML][HTML] In vitro electroporation detection methods–An overview

TB Napotnik, D Miklavčič - Bioelectrochemistry, 2018 - Elsevier
Exposing cells to an electric field leads to electroporation of the cell membrane which has
already been explored and used in a number of applications in medicine and food …

In vivo MRI cell tracking: clinical studies

JWM Bulte - American Journal of Roentgenology, 2009 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this review is to describe the principles of MRI cell tracking with
superparamagnetic iron oxides and the four clinical trials that have been performed …